China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of stular ganglion block on new-onset atrial fibrillation after off-pump coronary artery bypass grafting: A multicenter, randomized, placebo-controlled, blinded endpoint assessment prospective clinical trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131979
Registration Time: 2026/09/08
Type: Interventional study
Primary Sponsor: Zhongshan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341135
Published by HT Digital Content Services with permission from Health Daily Digest....